Literature DB >> 19888856

The 2009 American Thyroid Association Guidelines for management of thyroid nodules and differentiated thyroid cancer: progress on the road from consensus- to evidence-based practice.

Efisio Puxeddu, Sebastiano Filetti.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19888856     DOI： 10.1089/thy.2009.1601

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  12 in total

1.  Thyroid gland: Revised guidelines for the management of thyroid cancer.

Authors:  Kristien Boelaert
Journal:  Nat Rev Endocrinol       Date:  2010-04       Impact factor: 43.330

Review 2.  The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.

Authors:  Scott A Rivkees; Ernest L Mazzaferri; Frederik A Verburg; Christoph Reiners; Markus Luster; Christopher K Breuer; Catherine A Dinauer; Robert Udelsman
Journal:  Endocr Rev       Date:  2011-08-31       Impact factor: 19.871

3.  Surgery. Papillary thyroid cancer--how aggressive should surgery be?

Authors:  Sarah E Tevis; Herbert Chen
Journal:  Nat Rev Endocrinol       Date:  2015-02-17       Impact factor: 43.330

4.  Preoperative Diagnostic Categories of Noninvasive Follicular Thyroid Neoplasm with Papillary-Like Nuclear Features in Thyroid Core Needle Biopsy and Its Impact on Risk of Malignancy.

Authors:  Hee Young Na; Ji Won Woo; Jae Hoon Moon; June Young Choi; Woo-Jin Jeong; Yeo Koon Kim; Ji-Young Choe; So Yeon Park
Journal:  Endocr Pathol       Date:  2019-12       Impact factor: 3.943

5.  Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer.

Authors:  Kirk Jensen; Aneeta Patel; Victoria Hoperia; Alexander Larin; Andrew Bauer; Vasyl Vasko
Journal:  Exp Ther Med       Date:  2010-05-01       Impact factor: 2.447

6.  Stimulated thyroglobulin values above 5.6 ng/ml before radioactive iodine ablation treatment following levothyroxine withdrawal is associated with a 2.38-fold risk of relapse in Tg-ab negative subjects with differentiated thyroid cancer.

Authors:  U Mousa; A S Yikilmaz; A Nar
Journal:  Clin Transl Oncol       Date:  2017-03-03       Impact factor: 3.405

7.  Technological Advances Have Improved Surgical Outcome in Thyroid Surgery: Myth or Reality?

Authors:  H Aydin; S Ferahman; S Abdullayev; N A Sahbaz; A C Dural; D Guzey; C Akarsu; M Karabulut
Journal:  Acta Endocrinol (Buchar)       Date:  2021 Apr-Jun       Impact factor: 0.877

8.  T1a Versus T1b Differentiated Thyroid Cancers: Do We Need to Make the Distinction?

Authors:  Kevin L Anderson; Linda M Youngwirth; Randall P Scheri; Michael T Stang; Sanziana A Roman; Julie A Sosa
Journal:  Thyroid       Date:  2016-07-06       Impact factor: 6.568

9.  LncRNA-SLC6A9-5:2: A potent sensitizer in 131I-resistant papillary thyroid carcinoma with PARP-1 induction.

Authors:  Cheng Xiang; Mao-Lin Zhang; Qun-Zi Zhao; Qiu-Ping Xie; Hai-Chao Yan; Xing Yu; Ping Wang; Yong Wang
Journal:  Oncotarget       Date:  2017-04-04

10.  Symptomatic Primary Hyperparathyroidism as a Risk Factor for Differentiated Thyroid Cancer.

Authors:  Guadalupe Vargas-Ortega; Lourdes Balcázar-Hernández; Baldomero González-Virla; Claudia Ramírez-Rentería; Oriana Nieto-Guzmán; Ana Pamela Garrido-Mendoza; Marco Antonio Flores-Maya; Moisés Mercado; Mendoza-Zubieta Victoria
Journal:  J Thyroid Res       Date:  2018-11-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.